Insider Trading › PROF › Insiders
Profound Medical Corp.
PROF·Nasdaq·
Canada·Insider activity
$6.08
+0.05 (+0.83%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
PROF
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PROFS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of PROF were filed in the last 180 days. Newest filing May 20, 2025 (1 year ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by PROF insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$0Sales · 180 days
11Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of PROF common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
11 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Menawat Arun SwarupCEO · Director | Purchase | +12.0K | $4.73 | $57K | 587.1Kdirect | May 16, 2025 | May 20, 2025 | Form 4 ↗ |
| Menawat Arun SwarupCEO · Director | Purchase | +10.0K | $4.33 | $43K | 575.1Kdirect | May 15, 2025 | May 20, 2025 | Form 4 ↗ |
| HOFER MICHAELDirector | Sale | −40.0K | $0.16 | $6K | 500.0Kdirect | Dec 20, 2012 | Dec 20, 2012 | Form 4 ↗ |
| HOFER MICHAELDirector | Purchase | −40.0K | $0.16 | $6K | 540.0Kdirect | Dec 18, 2012 | Dec 19, 2012 | Form 4 ↗ |
| SVEINSON FREDERICK JDirector | Purchase | +500.0K | $0.00 | $0 | 500.0Kdirect | Jun 19, 2012 | Sep 19, 2012 | Form 4 ↗ |
| TEJADA FREDDirector | Purchase Amended | +500.0K | $0.00 | $0 | 500.0Kdirect | Jun 19, 2012 | Sep 10, 2012 | Form 4 ↗ |
| BLANCHET JUSTINChief Financial Officer · Director | Purchase Amended | +500.0K | $0.00 | $0 | 500.0Kdirect | Jun 19, 2012 | Sep 10, 2012 | Form 4 ↗ |
| ALIKAJ PERPARIMDirector | Purchase Amended | +500.0K | $0.00 | $0 | 500.0Kdirect | Jun 19, 2012 | Sep 10, 2012 | Form 4 ↗ |
| KHORCHIDIAN RAFFI10% owner | Sale | −3.0M | $0.00 | $0 | 17.0Mdirect | Jun 19, 2012 | Aug 21, 2012 | Form 4 ↗ |
| Schweitzer John H.Pres., CEO, Sec., Treas. · Director | Purchase | +500.0K | $0.00 | $0 | 72.5Mdirect | Jun 19, 2012 | Jul 18, 2012 | Form 4 ↗ |
| HOFER MICHAELDirector | Purchase | +500.0K | $0.00 | $0 | 500.0Kdirect | Jun 19, 2012 | Jul 18, 2012 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →
